Propel(x)
  • For Investors
  • For Founders
  • Portfolio
  • Insights
    • Podcast
    • Events
    • Blog
    • Glossary
    • Newsletter
    • Infographics
    • Angel Resources
  • Investor Login
  • Sign up to invest
  • For Investors
  • For Founders
  • Portfolio
  • Insights
    • Podcast
    • Events
    • Blog
    • Glossary
    • Newsletter
    • Infographics
    • Angel Resources
  • Investor Login
  • Sign up to invest
  • Investor Login
  • Sign up to invest
Priced Rounds vs. Convertible Debt

Fundraising 101: Priced Rounds vs. Convertible Debt

Propel(x) Team | August 3, 2016

Time to read: 2 minutes
3483
Share
Read More
Angel Investment Channel

Propel(x) Launches Angel Investment Channel Program with Breakout Labs

Propel(x) Team | July 26, 2016

Time to read: < 1 minute
1267
Share
Read More
bone regeneration

A Tricky Bone to Pick: Avitus Deal Profile

Propel(x) Team | July 20, 2016

Time to read: 4 minutes
1206
Share
Read More
term sheets

Fundraising 101: Terms Sheets

Propel(x) Team | July 15, 2016

Time to read: 3 minutes
1291
Share
Read More
startup evaluation questions

6 Questions To Evaluate a Startup

Propel(x) Team | July 12, 2016

Time to read: 3 minutes
2292
Share
Read More
How You Look at Industry Sectors

Changing How You Look at Industry Sectors and Technologies Could Increase Your Portfolio Diversification (and Mitigate Risk)

Swati Chaturvedi | July 7, 2016

Time to read: 3 minutes
1340
Share
Read More
tracking regeneration

Tracking Regeneration: Bell Biosystems Company Profile

Propel(x) Team | June 16, 2016

Time to read: 6 minutes
1103
Share
Read More
Saul Griffith - energy technology

A Hundred Ideas Coming Together: Saul Griffith’s Otherlab

Propel(x) Team | May 5, 2016

Time to read: 7 minutes
2498
Share
Read More
About Sensulin

Sensulin Deal Profile – Resetting the Insulin Clock

Propel(x) Team | May 3, 2016

Time to read: 6 minutes
1289
Share
Read More
  • 5
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ABOUT US
    • Company
    • Press Room
    • Industry Council
    • Channel Partners
    • Careers
  • How it works
    • Invest
    • Raise
    • FAQs
  • JOIN
    • Investors
    • Founders
  • Learn
    • Podcast
    • Events
    • Blog
    • Glossary
    • Newsletter
    • Infographics
    • Angel Resources
  • LEGAL
    • Terms of Use
    • Privacy Policy
    • Hubble Investments Privacy Notice
    • Business Continuity Plan
    • Form CRS
    • Conversation Starters

© 2022 PROPEL(X) - All Rights Reserved.

Propel(x) is an EvoNexus FinTech Incubator portfolio company.

  • How to Become an Angel Investor
  • Angel Investing Tips
  • How to Evaluate Startups
  • Portfolio Diversification

This site is operated by Propel(x) Inc. (“Propel(x)”), which is not a registered broker dealer. Propel(x) does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities posted here are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Propel(x) has not taken steps to verify the adequacy, accuracy, or completeness of the information. Neither Propel(x) nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind related to the adequacy, accuracy or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

Certain offerings posted on the platform and so designated are offered by Hubble Investments, Member FINRA / SIPC and an affiliate of Propel(x), located at 1 Franklin Parkway, Bldg # 930/1 - Fintech Suite, San Mateo CA 94403. Hubble Investments does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. This website is intended solely for qualified investors. Private investments are highly illiquid and risky and are not suitable for all investors. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.